Latest News
Read more
The battle for Australian-grown cannabis: quality vs global price wars
There is a buzz around Australia about “Made in Australia” products, including cannabis. Every country should be proud of its...
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
LISBON, PORTUGAL, August 29, 2024 – Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically...
Read more
Hanf Journal: Interview mit Michael Sassano, CEO von SOMAÍ Pharmaceuticals
Cannabis-Extrakte haben sich als vielversprechendes Therapeutikum in der modernen Medizin etabliert. Allerdings werden viele Anwenderinnen und Anwender vom Geschmack abgeschreckt,...
Read more
ICBC News: Legal Global Cannabis Products Are Becoming More Diverse
As the legal cannabis industry continues to expand to nearly every corner of the planet, the variety of products available...
Read more
What is Spain’s New Medical Cannabis Regulatory Framework?
Ultimately, patients deserve access to safer alternatives to current over-prescribed pharmaceutical medicines. Spain has become the latest large European country...
Read more
2024’s Hottest Global Medical Cannabis Market Trends
A massive dose of energy has jolted the global cannabis markets. The United States Department of Health and Human Services (HHS)...
Read more
European Cannabis Q2 2024 Quarterly Update
2024’s second quarter transpired strongly and predictably after the positive news of the 252-page United States Department of Health and Human...
Read more
CannaReporter: SOMAÍ’s Journey to Global Leadership in Cannabinoid Extracts
SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for...